Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Series introduction: the transcription factor NF-kappaB and human disease.

Literature DB >> 11134170

Series introduction: the transcription factor NF-kappaB and human disease.

A S Baldwin¹.

Abstract

Entities: Gene Species

Mesh：

Substances：
NF-kappa B

Year: 2001 PMID： 11134170 PMCID： PMC198555 DOI： 10.1172/JCI11891

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

40 in total

1. Characterization of a neuronal kappaB-binding factor distinct from NF-kappaB.

Authors: A M Moerman; X Mao; M M Lucas; S W Barger
Journal: Brain Res Mol Brain Res Date: 1999-04-20

2. Nuclear IkappaBbeta maintains persistent NF-kappaB activation in HIV-1-infected myeloid cells.

Authors: C DeLuca; L Petropoulos; D Zmeureanu; J Hiscott
Journal: J Biol Chem Date: 1999-05-07 Impact factor: 5.157

3. NF-kappaB is activated and promotes cell death in focal cerebral ischemia.

Authors: A Schneider; A Martin-Villalba; F Weih; J Vogel; T Wirth; M Schwaninger
Journal: Nat Med Date: 1999-05 Impact factor: 53.440

Review 4. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

Authors: S Ghosh; M J May; E B Kopp
Journal: Annu Rev Immunol Date: 1998 Impact factor: 28.527

5. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB.

Authors: C Y Wang; J C Cusack; R Liu; A S Baldwin
Journal: Nat Med Date: 1999-04 Impact factor: 53.440

6. Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells.

Authors: K E Traber; H Okamoto; C Kurono; M Baba; C Saliou; T Soji; L Packer; T Okamoto
Journal: Int Immunol Date: 1999-02 Impact factor: 4.823

7. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB.

Authors: A Dumont; S P Hehner; T G Hofmann; M Ueffing; W Dröge; M L Schmitz
Journal: Oncogene Date: 1999-01-21 Impact factor: 9.867

8. Herpes simplex type 1 induction of persistent NF-kappa B nuclear translocation increases the efficiency of virus replication.

Authors: A Patel; J Hanson; T I McLean; J Olgiate; M Hilton; W E Miller; S L Bachenheimer
Journal: Virology Date: 1998-08-01 Impact factor: 3.616

9. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint.

Authors: A V Miagkov; D V Kovalenko; C E Brown; J R Didsbury; J P Cogswell; S A Stimpson; A S Baldwin; S S Makarov
Journal: Proc Natl Acad Sci U S A Date: 1998-11-10 Impact factor: 11.205

10. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta.

Authors: M J Yin; Y Yamamoto; R B Gaynor
Journal: Nature Date: 1998-11-05 Impact factor: 49.962

270 in total

Review 1. NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer.

Authors: Hana Algül; Guido Adler; Roland M Schmid
Journal: Int J Gastrointest Cancer Date: 2002

2. Inhibitory Effects of JEUD-38, a New Sesquiterpene Lactone from Inula japonica Thunb, on LPS-Induced iNOS Expression in RAW264.7 Cells.

Authors: Xiaoqing Wang; Sheng-An Tang; Ran Wang; Yuling Qiu; Meihua Jin; Dexin Kong
Journal: Inflammation Date: 2015 Impact factor: 4.092

Series introduction: the transcription factor NF-kappaB and human disease.

1. Characterization of a neuronal kappaB-binding factor distinct from NF-kappaB.

2. Nuclear IkappaBbeta maintains persistent NF-kappaB activation in HIV-1-infected myeloid cells.

3. NF-kappaB is activated and promotes cell death in focal cerebral ischemia.

Review 4. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

5. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB.

6. Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells.

7. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB.

8. Herpes simplex type 1 induction of persistent NF-kappa B nuclear translocation increases the efficiency of virus replication.

9. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint.

10. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta.

Review 1. NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer.

2. Inhibitory Effects of JEUD-38, a New Sesquiterpene Lactone from Inula japonica Thunb, on LPS-Induced iNOS Expression in RAW264.7 Cells.

3. Tyrosine phosphorylation is required for IkappaB kinase-beta (IKKbeta) activation and function in osteoclastogenesis.

Review 4. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

5. Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention.

6. Salicylate-induced degeneration of cochlea spiral ganglion neurons-apoptosis signaling.

7. Tumor necrosis factor alpha induction of NF-kappaB requires the novel coactivator SIMPL.

8. Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity.

9. Evidence that reactive oxygen species do not mediate NF-kappaB activation.

10. Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandins.